Multiple labeling of a potent CX3CR1 antagonist for the treatment of multiple sclerosis
Several methods for the preparation of five isotopologues of the CX 3CR1 antagonist 1 were developed. Volatile and radioactive 1-chloro- and 1-bromo-ethyl-benzene was handled in [2′-14C] and [3′, 5′-3H] labeling of 1. d-Le